吸烟对多发性肌炎和皮肌炎临床及血清学表型的影响
研究在465例多发性肌炎(PM)和皮肌炎(DM)患者中评估吸烟与疾病特征、自身抗体、HLA类型及种族的关联。在白种人中,曾经吸烟者更易患PM、抗合成酶抗体和抗Jo-1抗体,较少有抗p155/140抗体;吸烟包年数与PM和间质性肺病(ILD)正相关,与抗p155/140抗体负相关。吸烟与HLA-DRB1*03:01可能交互影响PM、ILD及多种自身抗体的风险。
要点
- 白种人曾经吸烟者PM风险升高(校正OR=2.24),抗合成酶抗体(校正OR=1.93)和抗Jo-1抗体(校正OR=1.94)风险亦升高。
- 白种人曾经吸烟者抗p155/140抗体风险降低(校正OR=0.36)。
- 白种人重度吸烟者(≥20包年)PM、ILD和抗Jo-1抗体风险均升高。
核心结论
- 吸烟与白种人PM和DM的临床及自身抗体表型相关。
- 研究结果提示HLA-DRB1*03:01与吸烟可能交互影响白种人PM、ILD以及抗合成酶、抗Jo-1和抗p155/140抗体的风险。
研究设计与样本
- 在465例PM和DM患者中,采用多重逻辑回归评估吸烟与疾病特征、自身抗体、HLA类型及种族的关联。
主要发现
- 白种人曾经吸烟者(n=140)较从未吸烟者更易患PM(校正OR=2.24,95%CI:1.41–3.57)、抗合成酶抗体(校正OR=1.93,95%CI:1.12–3.34)和抗Jo-1抗体(校正OR=1.94,95%CI:1.08–3.46),较少有抗p155/140抗体(校正OR=0.36,95%CI:0.14–0.92)。
- 白种人曾经吸烟者ILD频率高于从未吸烟者,非裔美国人中该关系相反,但两者趋势均未达统计学显著。
- 白种人吸烟包年数与PM(校正OR=1.02,95%CI:1.002–1.04)和ILD(校正OR=1.02,95%CI:1.001–1.03)显著正相关,与抗p155/140抗体负相关(校正OR=0.93,95%CI:0.87–0.99)。
- 白种人重度吸烟者(≥20包年)较从未吸烟者更易患PM(校正OR=2.52,95%CI:1.25–5.09)、ILD(校正OR=2.48,95%CI:1.23–5.00)和抗Jo-1抗体(校正OR=2.65,95%CI:1.16–6.08)。
- 白种人中,携带HLA-DRB1*03:01等位基因的曾经吸烟者较无该等位基因的从未吸烟者PM、ILD、抗合成酶抗体和抗Jo-1抗体风险最高,仅具其一者风险居中,抗p155/140抗体呈相反模式。
关键数值与推荐
- 白种人曾经吸烟者PM校正OR=2.24(95%CI:1.41–3.57)。
- 白种人曾经吸烟者抗合成酶抗体校正OR=1.93(95%CI:1.12–3.34),抗Jo-1抗体校正OR=1.94(95%CI:1.08–3.46),抗p155/140抗体校正OR=0.36(95%CI:0.14–0.92)。
- 白种人吸烟包年数与PM校正OR=1.02(95%CI:1.002–1.04)、ILD校正OR=1.02(95%CI:1.001–1.03)正相关,与抗p155/140抗体校正OR=0.93(95%CI:0.87–0.99)负相关。
- 白种人重度吸烟者(≥20包年)PM校正OR=2.52(95%CI:1.25–5.09),ILD校正OR=2.48(95%CI:1.23–5.00),抗Jo-1抗体校正OR=2.65(95%CI:1.16–6.08)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cigarette smoking is associated with immune-mediated disorders. We explored the contribution of smoking to polymyositis (PM) and dermatomyositis (DM) phenotypes and attempted to determine whether cigarette smoking effects differ by race and genotype. METHODS: Associations of tobacco smoking with disease features, autoantibodies, HLA types, and race were evaluated using multiple logistic regressions in 465 patients. RESULTS: Caucasian ever-smokers (n = 140) were more likely to have PM (adjusted OR = 2.24, 95% CI: 1.41\x963.57), anti-synthetase (adjusted OR = 1.93, 95% CI: 1.12\x963.34) and anti-Jo-1 autoantibodies (adjusted OR = 1.94, 95% CI: 1.08\x963.46) and less likely to have anti-p155/140 autoantibodies (adjusted OR = 0.36, 95% CI: 0.14\x960.92). In Caucasians, ever-smokers had a greater interstitial lung disease (ILD) frequency than never-smokers, while in African-Americans this relationship was inverted, but neither trend reached statistical significance. Pack-years of cigarette smoking showed significant positive associations with PM (adjusted OR = 1.02, 95% CI: 1.002\x961.04) and ILD (adjusted OR = 1.02, 95% CI: 1.001\x961.03) and was inversely associated with anti-p155/140 autoantibodies (adjusted OR = 0.93, 95% CI: 0.87\x960.99) in Caucasians. Caucasian heavy smokers (=20 pack-years) were more likely to have PM (adjusted OR = 2.52, 95% CI: 1.25\x965.09), ILD (adjusted OR = 2.48, 95% CI: 1.23\x965.00) and anti-Jo-1 autoantibodies (adjusted OR = 2.65, 95% CI: 1.16\x966.08) than never-smokers. In Caucasians, compared to never-smokers without HLA-DRB1*03:01 allele, ever-smokers with HLA-DRB1*03:01 allele had the highest odds of PM, ILD, ASA, and anti-Jo-1 autoantibodies. Risks for those with only one of these two factors were intermediate. An inverse pattern was observed regarding anti-p155/140 autoantibodies. CONCLUSION: Tobacco smoking was associated with clinical and autoantibody phenotypes in Caucasians. Our findings also suggest possible interactions among HLA-DRB1*03:01 and smoking on the risk of PM and ILD, as well as, anti-synthetase, anti-Jo-1, and anti-p155/140 autoantibodies in Caucasians.
引用
- Schiffenbauer A, Faghihi-Kashani S, O'Hanlon TP, et al. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018. PMID: 29703532. doi:10.1016/j.semarthrit.2018.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。